Research output per year
Research output per year
Research output
- 3 Article
Search results
-
2017
An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma
Temam, S., Spicer, J., Farzaneh, F., Soria, J. C., Oppenheim, D., McGurk, M., Hollebecque, A., Sarini, J., Hussain, K., Soehrman Brossard, S., Manenti, L., Evers, S., Delmar, P., Di Scala, L., Mancao, C., Feuerhake, F., Andries, L., Ott, M. G., Passioukov, A. & Delord, J. P., 1 Nov 2017, In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 28, 11, p. 2827-2835Research output: Contribution to journal › Article › peer-review
Open Access19 Citations (Scopus) -
2014
Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy
Oppenheim, D. E., Spreafico, R., Etuk, A., Malone, D., Amofah, E., Pena-Murillo, C., Murray, T., McLaughlin, L., Choi, B. S., Allan, S., Belousov, A., Passioukov, A., Gerdes, C., Umana, P., Farzaneh, F. & Ross, P., 4 Mar 2014, In: BJC: British Journal of Cancer. 110, 5, p. 1221-1227 7 p., N/A.Research output: Contribution to journal › Article › peer-review
Open Access23 Citations (Scopus) -
Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma
Delord, J.-P., Tabernero, J., García-Carbonero, R., Cervantes, A., Gomez-Roca, C., Bergé, Y., Capdevila, J., Paz-Ares, L., Roda, D., Delmar, P., Oppenheim, D., Brossard, S. S., Farzaneh, F., Manenti, L., Passioukov, A., Ott, M. G. & Soria, J.-C., Feb 2014, In: European Journal of Cancer. 50, 3, p. 496-505 10 p., N/A.Research output: Contribution to journal › Article › peer-review
26 Citations (Scopus)